ArticleFrontiers in pediatrics2025
Diagnostic and therapeutic challenges of diffuse abdominal infantile hemangioma: a case report emphasizing multimodality imaging and multidisciplinary management.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diffuse abdominal infantile hemangioma (DAIH) is an exceptionally rare and life-threatening vascular anomaly, characterized by extensive infiltrative growth. It poses significant diagnostic challenges by mimicking malignancy and therapeutic difficulties due to involvement of critical structures. This case highlights the pivotal role of multimodality imaging and a multidisciplinary approach in its management. Case description: An 8-month-old female infant presented with abdominal distension and a history of hematochezia. Multimodality imaging (ultrasound, CT, and MRI) revealed an extensive, infiltrative vascular mass involving the mesentery and small bowel wall. Key findings included marked arterial enhancement, persistent venous pooling, flow voids, and secondary hemodynamic changes (portal/hepatic vein dilatation, aortic narrowing, and pulmonary hypertension). Given the lesion's unresectability and high embolization risk, ultrasound-guided biopsy was performed, confirming GLUT-1 positive infantile hemangioma. Oral propranolol therapy was initiated, leading to a dramatic reduction in lesion size and vascularity on follow-up imaging, along with resolution of pulmonary hypertension. Conclusions: This case underscores the characteristic imaging spectrum of DAIH, which radiologists must recognize to avoid misdiagnosis as malignancy. It reaffirms that a multidisciplinary strategy-centered on imaging-guided biopsy and propranolol as first-line therapy-can optimize outcomes even in severe cases, establishing a modern standard of care for such complex vascular anomalies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.